Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × temsirolimus × Clear all

NCT00429793 2019-07-24

Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

Phase 2 Completed

60 enrolled 13 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms